<unk> , sold under the brand name Galvus among others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.<unk>  inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.<unk>  has been shown to reduce hyperglycemia in type 2 diabetes mellitus.
Vildagliptin
Linagliptin
Liraglutide
Sitagliptin
Saxagliptin
Exenatide
Pioglitazone
Canagliflozin